Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
Masaaki MiyoTakeshi KatoTakayuki YoshinoTakeharu YamanakaHideaki BandoHironaga SatakeKentaro YamazakiHiroya TaniguchiEiji OkiMasahito KotakaKoji ObaYoshinori MiyataKei MuroYoshito KomatsuHideo BabaAkihito TsujiPublished in: BMC cancer (2020)
Clinicaltrials.gov NCT04097444 . Registered September 20, 2019, https://clinicaltrials.gov/ct2/show/study/NCT04097444 / Japan Registry of Clinical Trials jRCTs041190072. Registered October 9, 2019.